News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Gover Justin D.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/10/2023 |
4
| Gover Justin D. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns:
| Granted 28,000 options to buy
@ $38.39, valued at
$1.1M
|
|
05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/17/2020 |
4
| Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns:
| Exercised 39,060 shares
@ $0.0013, valued at
$50.8 Exercised 3,924 shares
@ $0.0013, valued at
$5.1 Sold 42,984 shares
@ $10.01, valued at
$430.3k
Exercised 22,800 shares
@ $0.0013, valued at
$29.6 Sold 22,800 shares
@ $10.02, valued at
$228.5k
Exercised 42,708 shares
@ $0.0013, valued at
$55.5 Sold 42,708 shares
@ $10.03, valued at
$428.4k
Exercised 39,060 options
@ $0 Exercised 3,924 options
@ $0 Exercised 22,800 options
@ $0 Exercised 42,708 options
@ $0 |
|
11/12/2020 |
4
| Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns:
| Exercised 3,600 shares
@ $0.0013, valued at
$4.7 Sold 7,200 shares
@ $10, valued at
$72k
Exercised 22,800 shares
@ $0.0013, valued at
$29.6 Exercised 13,917 shares
@ $0.0013, valued at
$18.1 Exercised 27,591 shares
@ $0.0013, valued at
$35.9 Sold 64,308 shares
@ $10.01, valued at
$643.7k
Exercised 3,600 options
@ $0 Exercised 22,800 options
@ $0 Exercised 13,917 options
@ $0 Exercised 27,591 options
@ $0 |
|
06/17/2020 |
4
| Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns:
| Exercised 4,164 shares
@ $0.0013, valued at
$5.4 Paid exercise price by delivering 2,076 shares
@ $10.23, valued at
$21.2k
Exercised 4,164 options
@ $0 |
|
06/08/2020 |
4
| Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns:
| Granted 480 options to buy
@ $0 Granted 287,904 options to buy
@ $0 |
|
03/04/2020 |
4
| Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns:
| Exercised 30,334 shares
@ $0.0013, valued at
$39.4 Exercised 17,510 shares
@ $0.0013, valued at
$22.8 Sold 24,456 shares
@ $8.31, valued at
$203.2k
Sold 8,400 shares
@ $8.4, valued at
$70.6k
Exercised 30,334 options
@ $0 Exercised 17,510 options
@ $0 |
|
02/28/2020 |
4
| Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns:
| Sold 9,480 shares
@ $9.01, valued at
$85.4k
Sold 1,644 shares
@ $9.17, valued at
$15.1k
Sold 876 shares
@ $9.21, valued at
$8.1k
|
|
02/05/2020 |
4
| Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns:
| Exercised 202,224 shares
@ $0.0013, valued at
$262.9 Sold 71,712 shares
@ $9.57, valued at
$686.3k
Sold 110,964 shares
@ $9.63, valued at
$1.1M
Sold 19,548 shares
@ $9.71, valued at
$189.8k
Exercised 202,224 options
@ $0 |
|
12/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/18/2019 |
4
| Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns:
| Granted 16,656 shares
@ $0.0013, valued at
$21.7 Granted 30,936 options to buy
@ $0 Granted 55,488 options to buy
@ $0 |
|
05/30/2019 |
4
| Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns:
| Exercised 202,224 shares
@ $0.0013, valued at
$262.9 Sold 52,680 shares
@ $15.08, valued at
$794.4k
Sold 26,784 shares
@ $15.17, valued at
$406.3k
Sold 56,736 shares
@ $15.25, valued at
$865.2k
Sold 40,728 shares
@ $15.35, valued at
$625.2k
Sold 19,284 shares
@ $15.43, valued at
$297.6k
Sold 6,012 shares
@ $15.49, valued at
$93.1k
Exercised 202,224 options
@ $0 |
|
03/19/2019 |
4
| Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns:
| Exercised 47,851 shares
@ $0.0013, valued at
$62.2 Disposed/sold 19 shares
@ $13.88, valued at
$263.7 Sold 23,400 shares
@ $14.01, valued at
$327.8k
Exercised 17,517 options
@ $0 Exercised 30,334 options
@ $0 |
|
03/05/2019 |
4
| Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns:
| Granted 119,472 options to buy
@ $0 Granted 226,752 options to buy
@ $0 Granted 17,004 options to buy
@ $0 |
|
02/28/2019 |
4
| Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns:
| Exercised 22,440 shares
@ $0.0013, valued at
$29.2 Sold 11,016 shares
@ $12.45, valued at
$137.1k
Sold 96 shares
@ $12.28, valued at
$1.2k
Exercised 22,440 options
@ $0 |
|
02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2019 |
4
| Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns:
| Sold 2,400 shares
@ $7.96, valued at
$19.1k
Sold 3,600 shares
@ $8.14, valued at
$29.3k
Sold 1,200 shares
@ $8.25, valued at
$9.9k
Sold 14,220 shares
@ $8.43, valued at
$119.9k
Sold 1,200 shares
@ $8.52, valued at
$10.2k
|
|
12/26/2018 |
4
| Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns:
| Exercised 45,240 shares
@ $0.0013, valued at
$58.8 Exercised 45,240 options
@ $0 |
|
|
|